These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 6399229)

  • 21. Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes.
    Price MO; Price FW
    Ophthalmology; 2006 Oct; 113(10):1785-90. PubMed ID: 16884779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of donor storage time on corneal allograft survival.
    Simon M; Fellner P; El-Shabrawi Y; Ardjomand N
    Ophthalmology; 2004 Aug; 111(8):1534-8. PubMed ID: 15288984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes observed in keratolimbal allograft.
    Maruyama-Hosoi F; Shimazaki J; Shimmura S; Tsubota K
    Cornea; 2006 May; 25(4):377-82. PubMed ID: 16670472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep Anterior Lamellar Keratoplasty (DALK): visual outcome and complications for a heterogeneous group of corneal pathologies.
    Noble BA; Agrawal A; Collins C; Saldana M; Brogden PR; Zuberbuhler B
    Cornea; 2007 Jan; 26(1):59-64. PubMed ID: 17198015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of primary adult penetrating keratoplasty in a Saudi Arabian population.
    Wagoner MD; Gonnah el-S; Al-Towerki AE;
    Cornea; 2009 Sep; 28(8):882-90. PubMed ID: 19654527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplantation antigens and keratoplasty.
    Stark WJ
    Dev Ophthalmol; 1981; 5():33-40. PubMed ID: 6177566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corneal transplant allograft reactions in unilateral, double corneal transplants.
    Rozenman J; Arentsen JJ; Laibson PR
    Cornea; 1985-1986; 4(1):25-9. PubMed ID: 3912114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Limbal stem cell transplantation from HLA-compatible living donors. Long term observation].
    Wylegała E; Tarnawska D; Wróblewska EM
    Klin Oczna; 2003; 105(6):378-83. PubMed ID: 15049259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-reported symptoms associated with graft reactions in high-risk patients in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group.
    Kamp MT; Fink NE; Enger C; Maguire MG; Stark WJ; Stulting RD
    Cornea; 1995 Jan; 14(1):43-8. PubMed ID: 7712736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Full-thickness central corneal grafts in lamellar keratoscleroplasty to treat limbal dermoids.
    Shen YD; Chen WL; Wang IJ; Hou YC; Hu FR
    Ophthalmology; 2005 Nov; 112(11):1955. PubMed ID: 16168487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limbal autograft and allograft transplantations in patients with corneal burns.
    Ozdemir O; Tekeli O; Ornek K; Arslanpençe A; Yalçindağ NF
    Eye (Lond); 2004 Mar; 18(3):241-8. PubMed ID: 15004571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Penetrating keratoplasty in Asian eyes: the Singapore Corneal Transplant Study.
    Tan DT; Janardhanan P; Zhou H; Chan YH; Htoon HM; Ang LP; Lim LS
    Ophthalmology; 2008 Jun; 115(6):975-982.e1. PubMed ID: 18061267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corneal graft transparency: is 100% an achievable goal?
    Zauberman H
    Isr J Med Sci; 1984 Feb; 20(2):101-3. PubMed ID: 6368464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunosuppressive therapy with cyclosporin A following penetrating keratoplasty].
    Gnad HD; Skorpik C; Radda TM; Paroussis P; Menapace R; Klemen UM
    Klin Monbl Augenheilkd; 1985 Nov; 187(5):398-400. PubMed ID: 3910946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Repeated Keratoplasties and graft rejection].
    Pouliquen Y; Rocher C
    Arch Ophtalmol Rev Gen Ophtalmol; 1975 Nov; 35(11):847-64. PubMed ID: 131536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of infant and child corneas for grafting.
    Bishara S; Levinger S; Frucht J; Zauberman H
    Isr J Med Sci; 1986 Nov; 22(11):817-9. PubMed ID: 3539869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and risk factors for corneal graft rejection.
    Sellami D; Abid S; Bouaouaja G; Ben Amor S; Kammoun B; Masmoudi M; Dabbeche K; Boumoud H; Ben Zina Z; Feki J
    Transplant Proc; 2007 Oct; 39(8):2609-11. PubMed ID: 17954190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corneal replacement using a synthetic hydrogel cornea, AlphaCor: device, preliminary outcomes and complications.
    Hicks CR; Crawford GJ; Lou X; Tan DT; Snibson GR; Sutton G; Downie N; Werner L; Chirila TV; Constable IJ
    Eye (Lond); 2003 Apr; 17(3):385-92. PubMed ID: 12724702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical aspects and treatment of immune reactions following penetrating normal-risk keratoplasty].
    Nguyen NX; Seitz B; Langenbucher A; Wenkel H; Cursiefen C
    Klin Monbl Augenheilkd; 2004 Jun; 221(6):467-72. PubMed ID: 15236106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.